There have been few, if any, studies of arthropod field populations quantifying the kinetics of evolution of phenotypic and genotypic resistance to chemicals in response to the presence or absence of selection pressure. A prospective intervention study was undertaken over 2 years in Mexico to measure changes in resistance phenotype and genotype in the presence or absence of pyrethroid selection pressure on field populations of Rhipicephalus (Boophilus) microplus ticks on 11 farms with varying degrees of pyrethroid resistance. The resistance phenotype was evaluated by bioassay in a larval packet test expressed as the resistance factor (RF) derived from probit analysis of dose mortality regressions, and resistance genotype by an allele-specific PCR (AS-PCR) to determine the frequency of a sodium channel mutation (F1550I) associated with pyrethroid resistance. To validate the AS-PCR, a Pyrosequencing™ method was developed to detect the F1550I mutation. There was good concordance with the genotypes identified by both Pyrosequencing™ and AS-PCR (Kappa: 0.85). On five farms cypermethrin (CY) was exclusively used at intervals and on six farms amitraz was used. On two of the five CY-treated farms, the experiment was prematurely terminated due to unacceptably high levels of tick resistance. For all five farms, after 8-24 months of continued selection pressure with CY, the RF had increased 2-125-fold. The frequency of the resistance allele increased on all five farms from a starting range of 5-46% to a range of 66-95% after 8-24 months. On six farms treated with amitraz neither the RF nor the frequency of the resistance allele changed. A clear correlation between the phenotype and genotype was found in three of four treated farms confirming that the F1550I mutation is a major cause of synthetic pyrethroid resistance in Mexico. These results show that the pyrethroid resistance trait is stable (> 2 years) and that resistance is acquired much faster than it is lost. Hence, alternation of pyrethroid acaricide with other chemicals is likely to lead to the stepwise acquisition of synthetic pyrethroid resistance but not additional prolongation of its efficacious lifespan. Copyright © 2011. Published by Elsevier Ltd.